Skip to main content

Published locations for New WHO recommendations promote dolutegravir benefits in the face of lowered risk signal for neural tube defects

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. New WHO recommendations promote dolutegravir benefits in the face of lowered risk signal for neural tube defects

User login

  • Reset your password
  • /content/new-who-recommendations-promote-dolutegravir-benefits-face-lowered-risk-signal-neural-tube
  • /familypracticenews/article/205126/hiv/new-who-recommendations-promote-dolutegravir-benefits-face
  • /idpractitioner/article/205126/hiv/new-who-recommendations-promote-dolutegravir-benefits-face-lowered
  • /internalmedicinenews/article/205126/hiv/new-who-recommendations-promote-dolutegravir-benefits-face
  • /obgynnews/article/205126/hiv/new-who-recommendations-promote-dolutegravir-benefits-face-lowered-risk
  • /pediatricnews/article/205126/hiv/new-who-recommendations-promote-dolutegravir-benefits-face-lowered
  • /jcomjournal/article/205126/hiv/new-who-recommendations-promote-dolutegravir-benefits-face-lowered
  • /obgyn/article/205126/hiv/new-who-recommendations-promote-dolutegravir-benefits-face-lowered-risk
  • /pediatrics/article/205126/hiv/new-who-recommendations-promote-dolutegravir-benefits-face-lowered
  • /infectiousdisease/article/205126/hiv/new-who-recommendations-promote-dolutegravir-benefits-face
  • /internalmedicine/article/205126/hiv/new-who-recommendations-promote-dolutegravir-benefits-face
  • /familymedicine/article/205126/hiv/new-who-recommendations-promote-dolutegravir-benefits-face-lowered